Javascript must be enabled to continue!
Abstract TMP114: Modulation Of P75ntr Improves Neuroprotection Following Ischemic Stroke
View through CrossRef
Background:
Stroke is a serious cause of mortality in the United States. Tissue plasminogen activator (tPA) is the only effective drug. However, it increases the risk of cerebral hemorrhage due to its narrow therapeutic window. Previous studies have shown the role of neurotrophins in several brain diseases. P75
NTR
which is the receptor of tumor necrosis family is highly expressed in stroke and associated with neuronal apoptosis. Downregulation of p75
NTR
attenuates brain injury. This study aims to find the role of p75
NTR
in the outcome of stroke.
Methods:
Two different sets of experiments were performed.
1.
Young adult C57BL/6 mice were subjected to ischemic stroke using intraluminal suture model. P75
NTR
modulator (LM11A-31) was administered following stroke. Brain samples were collected 24 hours after injury.
2.
Young adult C57BL/6 and p75 heterozygous mice were subjected to stroke using Rose Bengal photothrombotic method. Mice were tested for neurobehavioral analysis and samples were collected 72h after stroke.
Results:
We found that administration of LM11A-31 significantly reduced infarction volume, edema, and hemorrhagic transformation 24h after stroke in mice. Also, LM11A-31 reduced several inflammatory markers including tumor necrosis factor- alpha (TNF-α), nuclear factor kappa-light-chain (p-NFκb/t-NFκb), and c- Jun N-terminal kinases (p-JNK/t-JNK), and significantly increased the expression of several anti-inflammatory signaling, including protein kinase B (p-Akt/t-Akt) and extracellular signal-regulated kinase ½ (p-ERK1/2/t-ERK1/2) after stroke. Furthermore, we found that p75
NTR
heterozygous mice remarkably demonstrated less infarction, edema, and hemorrhagic transformation than wild-type mice after stroke. Moreover, p75
NTR
heterozygous significantly showed better motor function.
Conclusion:
This study suggests that p75
NTR
modulation can be a potential pharmacological target for improving the outcome of ischemic stroke.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract TMP114: Modulation Of P75ntr Improves Neuroprotection Following Ischemic Stroke
Description:
Background:
Stroke is a serious cause of mortality in the United States.
Tissue plasminogen activator (tPA) is the only effective drug.
However, it increases the risk of cerebral hemorrhage due to its narrow therapeutic window.
Previous studies have shown the role of neurotrophins in several brain diseases.
P75
NTR
which is the receptor of tumor necrosis family is highly expressed in stroke and associated with neuronal apoptosis.
Downregulation of p75
NTR
attenuates brain injury.
This study aims to find the role of p75
NTR
in the outcome of stroke.
Methods:
Two different sets of experiments were performed.
1.
Young adult C57BL/6 mice were subjected to ischemic stroke using intraluminal suture model.
P75
NTR
modulator (LM11A-31) was administered following stroke.
Brain samples were collected 24 hours after injury.
2.
Young adult C57BL/6 and p75 heterozygous mice were subjected to stroke using Rose Bengal photothrombotic method.
Mice were tested for neurobehavioral analysis and samples were collected 72h after stroke.
Results:
We found that administration of LM11A-31 significantly reduced infarction volume, edema, and hemorrhagic transformation 24h after stroke in mice.
Also, LM11A-31 reduced several inflammatory markers including tumor necrosis factor- alpha (TNF-α), nuclear factor kappa-light-chain (p-NFκb/t-NFκb), and c- Jun N-terminal kinases (p-JNK/t-JNK), and significantly increased the expression of several anti-inflammatory signaling, including protein kinase B (p-Akt/t-Akt) and extracellular signal-regulated kinase ½ (p-ERK1/2/t-ERK1/2) after stroke.
Furthermore, we found that p75
NTR
heterozygous mice remarkably demonstrated less infarction, edema, and hemorrhagic transformation than wild-type mice after stroke.
Moreover, p75
NTR
heterozygous significantly showed better motor function.
Conclusion:
This study suggests that p75
NTR
modulation can be a potential pharmacological target for improving the outcome of ischemic stroke.
Related Results
Iranian stroke model-how to involve health policymakers
Iranian stroke model-how to involve health policymakers
Stroke in Iran, with more than 83 million population, is a leading cause of disability and mortality in adults. Stroke has higher incidence in Iran comparing the global situation a...
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
According to epidemiological studies, the leading cause of morbidity, disability and mortality are cerebrovascular diseases, in particular ischemic and hemorrhagic strokes. In rece...
Extracellular cleavage of the p75 neurotrophin receptor is implicated in its pro‐survival effect in breast cancer cells
Extracellular cleavage of the p75 neurotrophin receptor is implicated in its pro‐survival effect in breast cancer cells
The p75 neurotrophin receptor (p75NTR) undergoes sequential proteolytic cleavages leading to the generation of a carboxyl‐terminal fragment (p75NTR‐CTF) and an intracellular domain...
EMSCs-Derived Exosomes Rescue p75NTR−/− -Mediated Osteogenesis Deficiency via PI3K/Akt/ERK1/2 Signaling Pathways
EMSCs-Derived Exosomes Rescue p75NTR−/− -Mediated Osteogenesis Deficiency via PI3K/Akt/ERK1/2 Signaling Pathways
The repair of the critical-sized bone defects remains a major challenge for orthopedic surgeons, particularly when osteogenesis is impaired by p75 neurotrophin receptor (p75NTR) de...
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
HIPERTENSI, USIA, JENIS KELAMIN DAN KEJADIAN STROKE DI RUANG RAWAT INAP STROKE RSUD dr. M. YUNUS BENGKULU
Hypertension, Age, Sex, and Stroke Incidence In Stroke Installation Room RSUD dr. M. Yunus BengkuluABSTRAKStroke adalah gejala-gejala defisit fungsi susunan saraf yang diakibatka...
Abstract TP294: The Impact of Chronic Kidney Disease Severity on Incident Acute Ischemic Stroke
Abstract TP294: The Impact of Chronic Kidney Disease Severity on Incident Acute Ischemic Stroke
Introduction:
Chronic kidney disease (CKD) and ischemic stroke are both associated with significant global disease burdens and share common risk factors. Understanding ...
Predictors of recurrent ischemic stroke in a sample of Egyptian stroke patients
Predictors of recurrent ischemic stroke in a sample of Egyptian stroke patients
Abstract
Background
Stroke is the third leading cause of mortality and a major cause of disability worldwide. Patients who experienced a first is...
Raising pre-transfusion HbS levels from 30% to 50% does not increase ischemic stroke recurrence in sickle cell disease: Results from a long-term single-center study
Raising pre-transfusion HbS levels from 30% to 50% does not increase ischemic stroke recurrence in sickle cell disease: Results from a long-term single-center study
Abstract
Introduction: Exchange transfusion remains the only strategy for the secondary prevention of ischemic stroke in...

